PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of artJournal's HomeManuscript SubmissionAims and ScopeAuthor GuidelinesEditorial BoardHome
 
AIDS Res Treat. 2012; 2012: 412643.
Published online May 7, 2012. doi:  10.1155/2012/412643
PMCID: PMC3352252
Achieving Universal Access for Human Immunodeficiency Virus and Tuberculosis: Potential Prevention Impact of an Integrated Multi-Disease Prevention Campaign in Kenya
Reuben Granich, 1 * Nicolas Muraguri, 2 Alexandre Doyen, 3 Navneet Garg, 4 and Brian G. Williams 5
1Treatment and Care Unit, Department of HIV/AIDS, World Health Organization, Avenue Appia 20, 1211 Geneva, Switzerland
2Ministry of Public Health and Sanitation, Government of Kenya, Nairobi, Kenya
3Vestergaard Frandsen (EA) Ltd., Waiyaki Way, ABC Place, P.O. Box 66889, Nairobi 00800, Kenya
4Innovation Centre, Vestergaard Frandsen, Chemin de Messidor 5-7, 1006 Lausanne, Switzerland
5South African Centre for Epidemiological Modeling and Analysis, Stellenbosch, South Africa
*Reuben Granich: granichr/at/who.int
Academic Editor: Anthony Harries
Received November 30, 2011; Revised January 27, 2012; Accepted January 28, 2012.
Abstract
In 2009, Government of Kenya with key stakeholders implemented an integrated multi-disease prevention campaign for water-borne diseases, malaria and HIV in Kisii District, Nyanza Province. The three day campaign, targeting 5000 people, included testing and counseling (HTC), condoms, long-lasting insecticide-treated bednets, and water filters. People with HIV were offered on-site CD4 cell counts, condoms, co-trimoxazole, and HIV clinic referral. We analysed the CD4 distributions from a district hospital cohort, campaign participants and from the 2007 Kenya Aids Indicator Survey (KAIS). Of the 5198 individuals participating in the campaign, all received HTC, 329 (6.3%) tested positive, and 255 (5%) were newly diagnosed (median CD4 cell count 536 cells/μL). The hospital cohort and KAIS results included 1,284 initial CD4 counts (median 348/L) and 306 initial CD4 counts (median 550/μL), respectively (campaign and KAIS CD4 distributions P = 0.346; hospital cohort distribution was lower P < 0.001 and P < 0.001). A Nyanza Province campaign strategy including ART <350 CD4 cell count could avert approximately 35,000 HIV infections and 1,240 TB cases annually. Community-based integrated public health campaigns could be a potential solution to reach universal access and Millennium Development Goals.
Articles from AIDS Research and Treatment are provided here courtesy of
Hindawi Publishing Corporation